A $2.9 billion deal, and nobody was laid off

Maddy's read

Nobody loses a job on a day like this, and that is exactly why it is worth reading slowly. A small team wakes up inside one of the largest pharmaceutical companies on earth, and every title in it quietly changes meaning. Head of something at a clinical-stage company becomes one of several directors in a function. Nobody was demoted and nobody was told anything. An org chart was drawn by people who have never met them, working from documents rather than conversations. In HR you have seen this every time: the integration team maps roles from job descriptions and headcount files, on a deadline, months before anyone is introduced.

Here is the possibility inside it. Every deal like this one ends the same way, with two org charts becoming one, and the seats in the new structure go to whoever is already legible in it. Being acquired is usually good news financially and almost always a reset professionally. The people who come out with their standing intact are the ones whose judgment was written down somewhere findable before the deal was announced, because that is the only version of them the mapping team can see.